Back

Non-invasive atrial cardiomyopathy diagnosis - how you measure the p-wave duration matters

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: ECG and rhythm monitoring Electrocardiography (ECG) EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Ms Silvia Becker

Karlsruhe Institute of Technology (KIT), Karlsruhe (Germany)

6 More presentations in this session

Presentation thumbnail
Can V6 R-wave peak time be used as a substitute for negative dV/dTmax to assess local electrical activation? Implications for left bundle branch area pacing
Doctor A. Spadotto (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
P-wave axis abnormalities in the UK Biobank: prevalence, associated outcomes, and genetic component
Mr O. Vad (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Comparison of a deep-learning algorithm with p-wave duration for non-pulmonary vein triggers
Mr A. Mann (Himachal Pradesh, IN)
Abstract Slides Video
Presentation thumbnail
Impact of continuous ECG monitoring after catheter ablation of persistent atrial fibrillation in patients with left ventricular systolic dysfunction - long term results from a single-centre registry
Mr J. Hurtado Soto (Dresden, DE)
Abstract Slides Video
Presentation thumbnail
SMART-ALERT study: continuous cardiac monitoring and real-time automated smartphone alerts for atrial fibrillation episodes
Doctor A. Briosa E Gala (Bern, CH)
Abstract Slides Video

Access the full session

Session thumbnail
ECG and rhythm monitoring
Video

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
Prevalence and progression of P-wave abnormalities in patients with atrial fibrillation
thumbnail
Congress Presentation
Comparison between Novel and Conventional Electrocardiographic Markers of Atrial Cardiomyopathy for identification of Persons at Risk for Ischemic Stroke
thumbnail
Congress Presentation
P-wave morphology based diagnosis of atrial cardiomyopathy in heart failure with preserved ejection fraction (HFpEF) patients with and without known atrial fibrillation (AF)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources